A Randomized, Double Blind, Placebo-controlled, Multiple Dose Study to Assess the Efficacy, Safety and Pharmacokinetics of Oral Nalbuphine, an Oral Soft Capsule, for Post-hemorrhoidectomy Pain Management
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Nalbuphine (Primary) ; Diclofenac
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors PhytoHealth
- 03 Nov 2015 Planned End Date changed from 1 Sep 2014 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 03 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Jul 2014 New trial record